Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

DYRK

Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) are conserved serine/threonine kinases. DYRKs have been implicated in cell survival, proliferation and differentiation, and in the pathology of Down Syndrome and Alzheimer's disease.

  • CK2/ERK8-IN-1
    T108271085822-09-8In house
    CK2/ERK8-IN-1 (TMCB) is a dual inhibitor of casein kinase 2 (CK2) (Ki: 0.25 µM) and ERK8 (IC50s: 0.50 μM) with pro-apoptotic efficacy. CK2/ERK8-IN-1 also binds to PIM1, DYRK1A, and HIPK2 (Kis: 8.65 µM, 11.9 µM, and 15.25 µM).
    • $30
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • ML 315
    T367071440251-53-5
    ML 315 is a selective Clk and DYRK inhibitor with potential anticancer activity for the study of neurological disorders.
    • $44
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • YK-2-69
    T695642619846-89-6In house
    YK-2-69 is a highly selective DYRK2 inhibitor with anti-prostate cancer effects.
    • $293
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • AnnH31
    T26632241809-12-1
    AnnH31 is a potent Dyrk1A inhibitor with an IC50 value of 81 nM.AnnH31 inhibits MAO-A with an IC50 of 3.2 μM.AnnH31 can be used as a probe to confirm the involvement of DYRK1A in cellular phosphorylation.
    • $213
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • ProINDY
    T23186719277-30-2
    ProINDY (Pro-indy) is a potent DYRK inhibitor that activates NFAT for the study of Down syndrome.
    • $92
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • ARN25068
    T613602649882-80-2In house
    ARN25068 is a potent inhibitor of GSK-3β, FYN, and DYRK1A protein kinases, exerting its activity in the sub-micromolar range. This compound effectively addresses tau hyperphosphorylation [1].
    • $115
    In Stock
    Size
    QTY
  • HTH-01-091
    T241522000209-42-5In house
    HTH-01-091 is a potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor (IC50: 10.5 nM).HTH-01-091 inhibits PIM1/2/3, RIPK2, DYRK3, smMLCK and CLK2. HTH-01-091 can be used to study breast cancer.
    • $296
    In Stock
    Size
    QTY
  • EHT 1610
    T152041425945-60-3In house
    EHT 1610 (EHT 5372) is a potent inhibitor of DYRK, with an IC50 of 0.36 nM and 0.59 nM for DYRK1A and DYRK1B, respectively. EHT 1610 has an inhibitory effect on leukemia, regulating cell cycle and inducing cell apoptosis.
    • $147
    In Stock
    Size
    QTY
  • CLK1-IN-3
    T720392922550-28-3In house
    Clk1-in-3 is a + selective and highly potent sexual Clk1 inhibitor with an IC50 of 5 nM and 300 pairs higher affinity than Dyrk1A. CLK1-IN-3 also showed highly effective inhibition of Clk2 and Clk4, with IC50 values of 42 and 108 nM, respectively. CLK1-IN-3 is effective in inducing autophagy in vitro and can be used for prevention and human treatment of acute liver injury (ALI).
    • $106
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Harmine
    T1711442-51-3
    Harmine (Telepathine) is an alkaloid isolated from seeds of Peganum harmala.
    • $50
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • AZ191
    T62571594092-37-1
    AZ191(IC50 of 17 nM) is an effective and specific DYRK1B inhibitor. The specificity of AZ191 for DYRK1B is about 5- and 110-fold greater over DYRK1A and DYRK2, respectively.
    • $39
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • ID-8
    T2431147591-46-6
    ID-8, a DYRK inhibitor, sustains embryonic stem cell self-renewal in long-term culture.
    • $40
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • ML167
    T26701285702-20-6
    ML167 (CID44968231) is a highly selective Cdc2-like kinase 4 (Clk4) inhibitor.
    • $32
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • AZ-Dyrk1B-33
    T143641679330-37-0
    AZ-Dyrk1B-33 (3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine) is a potent and selective Dyrk1B kinase inhibitor with an IC50 of 7 nM.
    • $67
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • LDN-192960
    TQ0111184582-62-5
    LDN-192960 is a potent inhibitor of Haspin and DYRK2 (IC50s: 10 nM and 48 nM).
    • $133
    In Stock
    Size
    QTY
  • DYRKs-IN-2
    T111331386980-04-6
    DYRKs-IN-2 has antitumor activity. DYRKs-IN-2 is a potent DYRKs inhibitor with IC50s of 30.6 nM and 12.8 nM for DYRK1B and DYRK1A, respectively.
    • $2,120
    Backorder
    Size
    QTY
  • DYRKs-IN-1
    T111321387090-01-8
    DYRKs-IN-1 has antitumor activity. DYRKs-IN-1 is a potent DYRKs (Dual-specificity tyrosine-phosphorylation-regulated kinases) inhibitor with IC50s of 9 nM and 5 nM for DYRK1B and DYRK1A, respectively.
    • $2,870
    Backorder
    Size
    QTY
  • CLK-IN-T3
    T149802109805-56-1
    CLK-IN-T3 is an inhibitor of CLK1, CLK2, and CLK3 with IC50s of 0.67, 15, and 110 nM. CLK-IN-T3 exhibits anti-cancer activity.
    • $53
    In Stock
    Size
    QTY
  • GNF2133
    T401872561414-56-8
    GNF2133 is an effective and selective inhibitor of DYRK1A with IC50s of 6.2 nM. GNF2133 can be used in studies about type 1 diabetes.
    • $158
    In Stock
    Size
    QTY
  • Harmine hydrochloride
    T2811343-27-1
    Harmine hydrochloride (telepathine hydrochloride) is extracted from Peganum Harmala Genus.
    • $41
    In Stock
    Size
    QTY
  • Protein kinase inhibitors 1
    T46361365986-44-2
    Protein kinase inhibitors 1 is a novel inhibitor of HIPK2 with an IC50 of 74 nM and Kd of 9.5 nM.
    • Inquiry Price
    Size
    QTY
  • INDY
    T155791169755-45-6
    INDY is an ATP-competitive inhibitor of Dyrk1A and Dyrk1B with IC50s of 0.24 μM and 0.23 μM and a Ki of 0.18 μM for Dyrk1A ATP pocket, respectively.
    • $55
    In Stock
    Size
    QTY
  • GNF4877
    T114472041073-22-5
    GNF4877 is a potent DYRK1A and GSK3β inhibitor (IC50s: 6 nM and 16 nM). It leads to blockade of nuclear factor of activated T-cells (NFATc) nuclear export and increased β-cell proliferation cells.
    • $205
    In Stock
    Size
    QTY
  • 7BIO
    T22012916440-85-2
    7-bromoindirubin-3'-oxime (7BIO) is a caspase independent nonapoptotic cell death inducer. 7BIO is an inhibitor of FLT3, DYRK1A, DYRK2, Aurora B and Aurora C kinases.
    • $30
    In Stock
    Size
    QTY
  • MBM-55
    T119602083622-09-5
    MBM-55 is an effective inhibitor of NIMA related kinase 2 (NEK2) with an IC50 of 1 nM. MBM-55 effectively inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis.
    • $187
    In Stock
    Size
    QTY
  • GSK-626616
    T154221025821-33-3
    GSK-626616 is a potent and orally bioavailable DYRK3 inhibitor (IC50: 0.7 nM). It inhibits other members of the DYRK family with similar potency. GSK-626616 is a potential therapy for the treatment of anemia.
    • $44
    In Stock
    Size
    QTY